spinal muscular atrophy |
Disease ID | 303 |
---|---|
Disease | spinal muscular atrophy |
Manually Symptom | UMLS | Name(Total Manually Symptoms:15) C2712323 | hypoglycaemia C2364118 | weakness C2364114 | tremor C2364051 | fatigue C1563743 | adiposity C1145670 | respiratory failure C0855197 | testicular cancer C0700208 | scoliosis C0342782 | depletion of mitochondrial dna C0268457 | aminoacidemia C0037315 | sleep-disordered breathing C0037315 | sleep disordered breathing C0027831 | neurofibromatosis 1 C0026848 | myopathy C0005940 | bone disease |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:5) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:2) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs713993043 | NA | 1778 | DYNC1H1 | umls:C0026847 | CLINVAR | NA | 0.121900093 | NA | DYNC1H1 | 14 | 101980380 | G | T |
rs75660264 | 21082361 | 6607 | SMN2 | umls:C0026847 | BeFree | We also show that while two SMN proteins harbouring SMA-causing point mutations (A2G and S262I) are efficiently targeted to CBs, they also display reduced nuclear movement. | 0.272351306 | 2011 | SMN1 | 5 | 70946127 | G | T |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |